Log In
Print
BCIQ
Print
Print this Print this
 

Mekinist, trametinib (GSK1120212)

Also known as: 1120212

  Manage Alerts
Collapse Summary General Information
Company Japan Tobacco Inc.
DescriptionSmall molecule inhibitor of MAP kinase kinase 1 (MAP2K1; MEK1) and MAP kinase kinase 2 (MAP2K2; MEK2)
Molecular Target MAP kinase kinase 1 (MAP2K1) (MEK1) ; MAP kinase kinase 2 (MAP2K2) (MEK2)
Mechanism of ActionKinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today